Medtronic plc insider trading
MDTfinancial statementsForm 4 filings on EDGAR174 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Medtronic plc bought $0 of stock in the open market, and 3 sold $6M. Officers and directors accounted for $0 of purchases and $6M of sales. The last reported transaction was an other by Lofton Kevin E on October 15, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 21, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $6MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
174 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Lofton Kevin E | Director | other | 182 | — | — | 9,977 | Oct 21, 2026 |
| Oct 15, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | open-market sale10b5-1 | 10,420 | $96.00 | $1M | 105,916 | Oct 16, 2026 |
| Oct 15, 2026 | Martha Geoffrey | Chairman and CEO, Director | open-market sale10b5-1 | 50,000 | $95.00 | $5M | 277,866 | Oct 16, 2026 |
| Oct 15, 2026 | Medtronic plc | 10% owner | other | 253M | — | — | 0 | Oct 16, 2026 |
| Sep 16, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | open-market sale | 1,483 | $93.65 | $139K | 42,186 | Sep 17, 2026 |
| Sep 15, 2026 | Blomquist Denise L. | Chief Accounting Officer | gift | 600 | $0.00 | — | 16,398 | Sep 16, 2026 |
| Aug 20, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | tax withholding | 1,084 | $92.30 | $100K | 116,336 | Aug 24, 2026 |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | award | 2,337 | $0.00 | — | 16,998 | Aug 4, 2026 |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | award | 5,769 | $0.00 | — | 39,928 | Aug 4, 2026 |
| Aug 3, 2026 | Thompson Kweli | EVP & President, Neuroscience | award | 6,923 | $0.00 | — | 35,390 | Aug 4, 2026 |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | award | 6,346 | $0.00 | — | 26,721 | Aug 4, 2026 |
| Aug 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | award | 11,537 | $0.00 | — | 49,645 | Aug 4, 2026 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | award | 10,960 | $0.00 | — | 71,273 | Aug 4, 2026 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | award | 46,147 | $0.00 | — | 117,420 | Aug 4, 2026 |
| Aug 3, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | award | 9,230 | $0.00 | — | 43,669 | Aug 4, 2026 |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO, Director | award | 41,533 | $0.00 | — | 327,866 | Aug 4, 2026 |
| Jul 31, 2026 | Blomquist Denise L. | Chief Accounting Officer | tax withholding | 212 | $85.39 | $18K | 14,661 | Aug 4, 2026 |
| Jul 31, 2026 | Walter Matthew R. | SVP, Chief HR Officer | tax withholding | 1,675 | $85.39 | $143K | 34,159 | Aug 4, 2026 |
| Jul 31, 2026 | Thompson Kweli | EVP & President, Neuroscience | tax withholding | 1,739 | $85.39 | $148K | 28,467 | Aug 4, 2026 |
| Jul 31, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | tax withholding | 3,356 | $85.39 | $287K | 60,313 | Aug 4, 2026 |
| Jul 31, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | tax withholding | 3,074 | $85.39 | $262K | 34,439 | Aug 4, 2026 |
| Jul 31, 2026 | Martha Geoffrey | Chairman and CEO, Director | tax withholding | 15,810 | $85.39 | $1M | 286,333 | Aug 4, 2026 |
| Jul 28, 2026 | Quinn Michelle | EVP, GC and Secretary | tax withholding | 2,069 | $86.88 | $180K | 20,375 | Jul 29, 2026 |
| Jul 8, 2026 | Walter Matthew R. | SVP, Chief HR Officer | open-market sale10b5-1 | 3,102 | $83.15 | $258K | 35,694 | Jul 9, 2026 |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | open-market sale | 3,961 | $80.44 | $319K | 37,455 | Jun 9, 2026 |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | open-market sale | 228 | $80.45 | $18K | 37,227 | Jun 9, 2026 |
| Jun 5, 2026 | Blomquist Denise L. | Chief Accounting Officer | tax withholding | 237 | $83.32 | $20K | 14,737 | Jun 8, 2026 |
| Jun 4, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | tax withholding | 6,817 | $83.32 | $568K | 41,416 | Jun 8, 2026 |
| Jun 4, 2026 | Martha Geoffrey | Chairman and CEO, Director | tax withholding | 41,936 | $83.32 | $3M | 301,163 | Jun 8, 2026 |
| Jun 4, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | tax withholding | 7,471 | $83.32 | $622K | 63,122 | Jun 8, 2026 |
| Jun 4, 2026 | Walter Matthew R. | SVP, Chief HR Officer | tax withholding | 2,840 | $83.32 | $237K | 38,689 | Jun 8, 2026 |
| May 26, 2026 | Walter Matthew R. | SVP, Chief HR Officer | option exercise | 9,149 | $0.00 | — | 41,529 | May 28, 2026 |
| May 26, 2026 | Wall Brett A. | EVP & Pres Neuroscience | option exercise | 26,907 | $0.00 | — | 82,183 | May 28, 2026 |
| May 26, 2026 | Martha Geoffrey | Chairman and CEO, Director | option exercise | 94,963 | $0.00 | — | 343,099 | May 28, 2026 |
| May 26, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | option exercise | 18,994 | $0.00 | — | 70,593 | May 28, 2026 |
| May 26, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | option exercise | 15,195 | $0.00 | — | 48,233 | May 28, 2026 |
| May 26, 2026 | Blomquist Denise L. | Chief Accounting Officer | option exercise | 1,712 | $0.00 | — | 14,974 | May 28, 2026 |
| May 1, 2026 | Walter Matthew R. | SVP, Chief HR Officer | tax withholding | 35 | $80.00 | $3K | 32,380 | May 4, 2026 |
| Apr 28, 2026 | Blomquist Denise L. | Chief Accounting Officer | tax withholding | 318 | $81.90 | $26K | 13,262 | Apr 29, 2026 |
| Apr 28, 2026 | Powell Kendall J | Director | tax withholding | 207 | $81.90 | $17K | 51,380 | Apr 29, 2026 |
| Apr 28, 2026 | Nabel Elizabeth G | Director | tax withholding | 207 | $81.90 | $17K | 19,584 | Apr 29, 2026 |
| Apr 28, 2026 | Lofton Kevin E | Director | tax withholding | 207 | $81.90 | $17K | 10,140 | Apr 29, 2026 |
| Apr 28, 2026 | Lewis Gregory P | Director | tax withholding | 207 | $81.90 | $17K | 5,754 | Apr 29, 2026 |
| Apr 28, 2026 | Hogan Randall J | Director | tax withholding | 207 | $81.90 | $17K | 48,998 | Apr 29, 2026 |
| Apr 28, 2026 | Fonseca Lidia | Director | tax withholding | 207 | $81.90 | $17K | 7,644 | Apr 29, 2026 |
| Apr 28, 2026 | Donnelly Scott C | Director | tax withholding | 207 | $81.90 | $17K | 23,679 | Apr 29, 2026 |
| Apr 28, 2026 | Arnold Craig | Director | tax withholding | 207 | $81.90 | $17K | 42,185 | Apr 29, 2026 |
| Apr 27, 2026 | Blomquist Denise L. | Chief Accounting Officer | award | 1,508 | $0.00 | — | 13,580 | Apr 29, 2026 |
| Apr 27, 2026 | Powell Kendall J | Director | award | 2,111 | $0.00 | — | 51,587 | Apr 29, 2026 |
| Apr 27, 2026 | Nabel Elizabeth G | Director | award | 2,111 | $0.00 | — | 19,791 | Apr 29, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Kiil Harry Skip | EVP & President Cardiovascular | Sep 16, 2026 | open-market sale | 42,186 | — | $6M (8) | 0 of 8 |
| Martha Geoffrey | Chairman and CEO, Director | Oct 15, 2026 | open-market sale | 277,866 | — | $5M (1) | 1 of 1 |
| Smith Gregory L | EVP Global Ops & Supply Chain | Nov 19, 2025 | open-market sale | 46,016 | — | $3M (7) | 0 of 7 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | Oct 15, 2026 | open-market sale | 105,916 | — | $1M (1) | 1 of 1 |
| Walter Matthew R. | SVP, Chief HR Officer | Aug 3, 2026 | award | 39,928 | — | $258K (1) | 1 of 1 |
| Blomquist Denise L. | Chief Accounting Officer | Sep 15, 2026 | gift | 16,398 | — | — | — |
| Wall Brett A. | EVP & Pres Neuroscience | May 26, 2026 | option exercise | 82,183 | — | — | — |
| Pieton Thierry | EVP & Chief Financial Officer | Aug 3, 2026 | award | 49,645 | — | — | — |
| Lofton Kevin E | Director | Oct 15, 2026 | other | 9,977 | — | — | — |
| Quinn Michelle | EVP, GC and Secretary | Aug 3, 2026 | award | 26,721 | — | — | — |
| Powell Kendall J | Director | Apr 28, 2026 | tax withholding | 51,380 | — | — | — |
| Nabel Elizabeth G | Director | Apr 28, 2026 | tax withholding | 19,584 | — | — | — |
| Lewis Gregory P | Director | Apr 28, 2026 | tax withholding | 5,754 | — | — | — |
| Hogan Randall J | Director | Apr 28, 2026 | tax withholding | 48,998 | — | — | — |
| Fonseca Lidia | Director | Apr 28, 2026 | tax withholding | 7,644 | — | — | — |
| Donnelly Scott C | Director | Apr 28, 2026 | tax withholding | 23,679 | — | — | — |
| Arnold Craig | Director | Apr 28, 2026 | tax withholding | 42,185 | — | — | — |
| Jellison William R | Director | Apr 27, 2026 | award | 6,444 | — | — | — |
| Thompson Kweli | EVP & President, Neuroscience | Aug 3, 2026 | award | 35,390 | — | — | — |
| Goldsmith Andrea Jo | Director | Apr 29, 2025 | tax withholding | 10,247 | — | — | — |
| Corona Gary Louis | Interim CFO | Jan 21, 2025 | award | 44,255 | — | — | — |
| Fong Ivan K | EVP GENERAL COUNSEL & SECR | Dec 16, 2024 | tax withholding | 54,692 | — | — | — |
| Medtronic plc | 10% owner | Oct 15, 2026 | other | 0 | — | — | — |
| Lee Joon Sup | Director | Apr 27, 2026 | award | 1,803 | — | — | — |
| Groetelaars John P | Director | Apr 27, 2026 | award | 1,444 | — | — | — |
| Salmon Sean | EVP & President Cardiovascular | Dec 16, 2024 | tax withholding | 64,722 | — | — | — |
| Kirk Jennifer M | Chief Accounting Officer | Dec 6, 2024 | tax withholding | 28,011 | — | — | — |
Questions
Are Medtronic plc insiders buying or selling?
Over the twelve months to November 1, 2026, 5 insiders at Medtronic plc sold $15M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $15M. Only open-market purchases and sales are counted.
Who sold the most Medtronic plc stock in the last year?
Kiil Harry Skip (EVP & President Cardiovascular) sold $6M in 8 open-market sales over the twelve months to November 1, 2026.
Do Medtronic plc executives sell under 10b5-1 plans?
3 of the 18 open-market sales in the last twelve months (17%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Medtronic plc
- Medtronic plc financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.